NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the market closed on Tuesday that its third-quarter revenues rose 4 percent driven by strong clinical diagnostics sales.

The firm reported total revenues of $461.1 million for the three-month period ended Sept. 30, compared to revenues of $441.8 million for the third quarter of 2008. On a currency-neutral basis, Bio-Rad's revenue growth for the quarter was 11 percent.

It beat analysts' consensus estimate on both the top and bottom line.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.